Please assess the completion status of the following clinical trial:

Trial Title: Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Have written informed consent provided by legal parent, guardian, or authorized agent prior to participation in the study or study-only related procedures.~2. Be between birth (28 weeks to \< 40 weeks gestational age) to ≤ 16 years of age.~3. Have new (less than 7 days) onset of fever, documented by temperature greater than or equal to 101.0 ºF (38.3 ºC).~Exclusion Criteria:~1. Have inadequate intravenous access.~2. Have received antipyretic drug therapy within 2 hours before dosing.~3. Have any history of allergy or hypersensitivity to NSAIDs or aspirin.~4. Have received another investigational drug within the past 30 days.~5. Be otherwise unsuitable for the study, in the opinion of the Investigator.~6. Have a fever due to hyperthermia.~7. Pregnant or nursing.

- Gender: ALL
- Minimum Age: None
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- ibuprofen (Type: EXPERIMENTAL): Ibuprofen, 10 mg/kg
- Acetaminophen (Type: ACTIVE_COMPARATOR): Acetaminophen, 10mg/kg

Based on this trial design, predict the completion outcome and termination type (if applicable).